The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dengue Vaccines Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Dengue Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Dengue Vaccines market size is estimated to be worth US$ 412.2 million in 2021 and is forecast to a readjusted size of USD 1010.9 million by 2028 with a CAGR of 13.7% during review period. Public Sector accounting for % of the Dengue Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Dengvaxia segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Dengue Vaccines include Sanofi, Takeda, , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Dengue Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Dengvaxia
TAK-003
Others
Market segment by Application, can be divided into
Public Sector
Private Sector
Market segment by players, this report covers
Sanofi
Takeda
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Dengue Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Dengue Vaccines, with revenue, gross margin and global market share of Dengue Vaccines from 2019 to 2022.
Chapter 3, the Dengue Vaccines competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Dengue Vaccines market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Dengue Vaccines research findings and conclusion, appendix and data source.
Geographical Area
Global
The Dengue Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Dengue Vaccines market size is estimated to be worth US$ 412.2 million in 2021 and is forecast to a readjusted size of USD 1010.9 million by 2028 with a CAGR of 13.7% during review period. Public Sector accounting for % of the Dengue Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Dengvaxia segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Dengue Vaccines include Sanofi, Takeda, , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Dengue Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Dengvaxia
TAK-003
Others
Market segment by Application, can be divided into
Public Sector
Private Sector
Market segment by players, this report covers
Sanofi
Takeda
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Dengue Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Dengue Vaccines, with revenue, gross margin and global market share of Dengue Vaccines from 2019 to 2022.
Chapter 3, the Dengue Vaccines competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Dengue Vaccines market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Dengue Vaccines research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Dengue Vaccines
1.2 Classification of Dengue Vaccines by Type
1.2.1 Overview: Global Dengue Vaccines Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Dengue Vaccines Revenue Market Share by Type in 2021
1.2.3 Dengvaxia
1.2.4 TAK-003
1.2.5 Others
1.3 Global Dengue Vaccines Market by Application
1.3.1 Overview: Global Dengue Vaccines Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Public Sector
1.3.3 Private Sector
1.4 Global Dengue Vaccines Market Size & Forecast
1.5 Global Dengue Vaccines Market Size and Forecast by Region
1.5.1 Global Dengue Vaccines Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Dengue Vaccines Market Size by Region, (2017-2022)
1.5.3 North America Dengue Vaccines Market Size and Prospect (2017-2028)
1.5.4 Europe Dengue Vaccines Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Dengue Vaccines Market Size and Prospect (2017-2028)
1.5.6 South America Dengue Vaccines Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Dengue Vaccines Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Dengue Vaccines Market Drivers
1.6.2 Dengue Vaccines Market Restraints
1.6.3 Dengue Vaccines Trends Analysis
2 Company Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Dengue Vaccines Product and Solutions
2.1.4 Sanofi Dengue Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Sanofi Recent Developments and Future Plans
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda Dengue Vaccines Product and Solutions
2.2.4 Takeda Dengue Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Takeda Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Dengue Vaccines Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Dengue Vaccines Players Market Share in 2021
3.2.2 Top 10 Dengue Vaccines Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Dengue Vaccines Players Head Office, Products and Services Provided
3.4 Dengue Vaccines Mergers & Acquisitions
3.5 Dengue Vaccines New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Dengue Vaccines Revenue and Market Share by Type (2017-2022)
4.2 Global Dengue Vaccines Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Dengue Vaccines Revenue Market Share by Application (2017-2022)
5.2 Global Dengue Vaccines Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Dengue Vaccines Revenue by Type (2017-2028)
6.2 North America Dengue Vaccines Revenue by Application (2017-2028)
6.3 North America Dengue Vaccines Market Size by Country
6.3.1 North America Dengue Vaccines Revenue by Country (2017-2028)
6.3.2 United States Dengue Vaccines Market Size and Forecast (2017-2028)
6.3.3 Canada Dengue Vaccines Market Size and Forecast (2017-2028)
6.3.4 Mexico Dengue Vaccines Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Dengue Vaccines Revenue by Type (2017-2028)
7.2 Europe Dengue Vaccines Revenue by Application (2017-2028)
7.3 Europe Dengue Vaccines Market Size by Country
7.3.1 Europe Dengue Vaccines Revenue by Country (2017-2028)
7.3.2 Germany Dengue Vaccines Market Size and Forecast (2017-2028)
7.3.3 France Dengue Vaccines Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Dengue Vaccines Market Size and Forecast (2017-2028)
7.3.5 Russia Dengue Vaccines Market Size and Forecast (2017-2028)
7.3.6 Italy Dengue Vaccines Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Dengue Vaccines Revenue by Type (2017-2028)
8.2 Asia-Pacific Dengue Vaccines Revenue by Application (2017-2028)
8.3 Asia-Pacific Dengue Vaccines Market Size by Region
8.3.1 Asia-Pacific Dengue Vaccines Revenue by Region (2017-2028)
8.3.2 China Dengue Vaccines Market Size and Forecast (2017-2028)
8.3.3 Japan Dengue Vaccines Market Size and Forecast (2017-2028)
8.3.4 South Korea Dengue Vaccines Market Size and Forecast (2017-2028)
8.3.5 India Dengue Vaccines Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Dengue Vaccines Market Size and Forecast (2017-2028)
8.3.7 Australia Dengue Vaccines Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Dengue Vaccines Revenue by Type (2017-2028)
9.2 South America Dengue Vaccines Revenue by Application (2017-2028)
9.3 South America Dengue Vaccines Market Size by Country
9.3.1 South America Dengue Vaccines Revenue by Country (2017-2028)
9.3.2 Brazil Dengue Vaccines Market Size and Forecast (2017-2028)
9.3.3 Argentina Dengue Vaccines Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Dengue Vaccines Revenue by Type (2017-2028)
10.2 Middle East & Africa Dengue Vaccines Revenue by Application (2017-2028)
10.3 Middle East & Africa Dengue Vaccines Market Size by Country
10.3.1 Middle East & Africa Dengue Vaccines Revenue by Country (2017-2028)
10.3.2 Turkey Dengue Vaccines Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Dengue Vaccines Market Size and Forecast (2017-2028)
10.3.4 UAE Dengue Vaccines Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Dengue Vaccines Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Dengue Vaccines Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Dengue Vaccines Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Dengue Vaccines Revenue (USD Million) by Region (2017-2022)
Table 5. Global Dengue Vaccines Revenue Market Share by Region (2023-2028)
Table 6. Sanofi Corporate Information, Head Office, and Major Competitors
Table 7. Sanofi Major Business
Table 8. Sanofi Dengue Vaccines Product and Solutions
Table 9. Sanofi Dengue Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Takeda Corporate Information, Head Office, and Major Competitors
Table 11. Takeda Major Business
Table 12. Takeda Dengue Vaccines Product and Solutions
Table 13. Takeda Dengue Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Global Dengue Vaccines Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 15. Global Dengue Vaccines Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 16. Breakdown of Dengue Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 17. Dengue Vaccines Players Head Office, Products and Services Provided
Table 18. Dengue Vaccines Mergers & Acquisitions in the Past Five Years
Table 19. Dengue Vaccines New Entrants and Expansion Plans
Table 20. Global Dengue Vaccines Revenue (USD Million) by Type (2017-2022)
Table 21. Global Dengue Vaccines Revenue Share by Type (2017-2022)
Table 22. Global Dengue Vaccines Revenue Forecast by Type (2023-2028)
Table 23. Global Dengue Vaccines Revenue by Application (2017-2022)
Table 24. Global Dengue Vaccines Revenue Forecast by Application (2023-2028)
Table 25. North America Dengue Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 26. North America Dengue Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 27. North America Dengue Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 28. North America Dengue Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 29. North America Dengue Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 30. North America Dengue Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 31. Europe Dengue Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 32. Europe Dengue Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 33. Europe Dengue Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 34. Europe Dengue Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 35. Europe Dengue Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 36. Europe Dengue Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 37. Asia-Pacific Dengue Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 38. Asia-Pacific Dengue Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 39. Asia-Pacific Dengue Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 40. Asia-Pacific Dengue Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 41. Asia-Pacific Dengue Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 42. Asia-Pacific Dengue Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 43. South America Dengue Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 44. South America Dengue Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 45. South America Dengue Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 46. South America Dengue Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 47. South America Dengue Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 48. South America Dengue Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 49. Middle East & Africa Dengue Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 50. Middle East & Africa Dengue Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 51. Middle East & Africa Dengue Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 52. Middle East & Africa Dengue Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 53. Middle East & Africa Dengue Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 54. Middle East & Africa Dengue Vaccines Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Dengue Vaccines Picture
Figure 2. Global Dengue Vaccines Revenue Market Share by Type in 2021
Figure 3. Dengvaxia
Figure 4. TAK-003
Figure 5. Others
Figure 6. Dengue Vaccines Revenue Market Share by Application in 2021
Figure 7. Public Sector Picture
Figure 8. Private Sector Picture
Figure 9. Global Dengue Vaccines Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Dengue Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Dengue Vaccines Revenue Market Share by Region (2017-2028)
Figure 12. Global Dengue Vaccines Revenue Market Share by Region in 2021
Figure 13. North America Dengue Vaccines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Dengue Vaccines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Dengue Vaccines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Dengue Vaccines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Dengue Vaccines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Dengue Vaccines Market Drivers
Figure 19. Dengue Vaccines Market Restraints
Figure 20. Dengue Vaccines Market Trends
Figure 21. Sanofi Recent Developments and Future Plans
Figure 22. Takeda Recent Developments and Future Plans
Figure 23. Global Dengue Vaccines Revenue Share by Players in 2021
Figure 24. Dengue Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 25. Global Top 3 Players Dengue Vaccines Revenue Market Share in 2021
Figure 26. Global Top 10 Players Dengue Vaccines Revenue Market Share in 2021
Figure 27. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 28. Global Dengue Vaccines Revenue Share by Type in 2021
Figure 29. Global Dengue Vaccines Market Share Forecast by Type (2023-2028)
Figure 30. Global Dengue Vaccines Revenue Share by Application in 2021
Figure 31. Global Dengue Vaccines Market Share Forecast by Application (2023-2028)
Figure 32. North America Dengue Vaccines Sales Market Share by Type (2017-2028)
Figure 33. North America Dengue Vaccines Sales Market Share by Application (2017-2028)
Figure 34. North America Dengue Vaccines Revenue Market Share by Country (2017-2028)
Figure 35. United States Dengue Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 36. Canada Dengue Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 37. Mexico Dengue Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 38. Europe Dengue Vaccines Sales Market Share by Type (2017-2028)
Figure 39. Europe Dengue Vaccines Sales Market Share by Application (2017-2028)
Figure 40. Europe Dengue Vaccines Revenue Market Share by Country (2017-2028)
Figure 41. Germany Dengue Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. France Dengue Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. United Kingdom Dengue Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Russia Dengue Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Italy Dengue Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Asia-Pacific Dengue Vaccines Sales Market Share by Type (2017-2028)
Figure 47. Asia-Pacific Dengue Vaccines Sales Market Share by Application (2017-2028)
Figure 48. Asia-Pacific Dengue Vaccines Revenue Market Share by Region (2017-2028)
Figure 49. China Dengue Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Japan Dengue Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. South Korea Dengue Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. India Dengue Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Southeast Asia Dengue Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Australia Dengue Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. South America Dengue Vaccines Sales Market Share by Type (2017-2028)
Figure 56. South America Dengue Vaccines Sales Market Share by Application (2017-2028)
Figure 57. South America Dengue Vaccines Revenue Market Share by Country (2017-2028)
Figure 58. Brazil Dengue Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Argentina Dengue Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Middle East and Africa Dengue Vaccines Sales Market Share by Type (2017-2028)
Figure 61. Middle East and Africa Dengue Vaccines Sales Market Share by Application (2017-2028)
Figure 62. Middle East and Africa Dengue Vaccines Revenue Market Share by Country (2017-2028)
Figure 63. Turkey Dengue Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Saudi Arabia Dengue Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. UAE Dengue Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Methodology
Figure 67. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
